https://www.selleckchem.com/products/etc-1002.html
abnormalities at the diagnosis of MM are of great clinical significance in predicting patient response to therapy and survival. Further, 1q21 and FGFR3 mutations could potentially be used in combination with status, to better predict patient survival and guide for selecting high-risk patients to advance patient treatment strategies. TP53 abnormalities at the diagnosis of MM are of great clinical significance in predicting patient response to therapy and survival. Further, 1q21 and FGFR3 mutations could potentially be used in combinatio